ImmunoGen (IMGN) Shares Spike On Licensing Deal with Japan’s Tekada

ImmunoGen, Inc. (IMGN) is seeing a big move Monday, as the company’s shares surged by over 16% on the day on news of a licensing agreement with Japanese company Takeda Pharmaceutical. Under the terms of the agreement, ImmunoGen will get $20 million up front from Takeda and is eligible for milestone payments potentially totaling up […] View the full post at: ImmunoGen (IMGN) Shares Spike On Licensing Deal with Japan’s Tekada Related posts: Atlas Pipeline (APL) Shares Soar On Nat Gas Asset Sale Warren Buffett’s Holding Company Reduces Stake in Moody’s Shares CIT Group Cuts Deal with Key Bondholders to Avoid Bankruptcy